Status:
ACTIVE_NOT_RECRUITING
Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Stem Cell Transplant
Eligibility:
All Genders
60+ years
Brief Summary
Patients older than 60 years are more and more transplanted. Comprehensive geriatric assessment (CGA) have been developed and are currently used in patients with cancer, it has been correlated with th...
Eligibility Criteria
Inclusion
- 60 years or more at time of transplantation
- Patient receiving a hematopoietic stem cell allograft for myeloid hemopathy (myeloid acute leukemia, myelodysplastic syndrome, Myeloproliferative neoplasm) or for an Acute lymphoblastic leukemia
- No opposition to participate
Exclusion
- Patient opposed to the protocol
- Vulnerable patients protected by curatorship or administrative supervision
- Patients not covered by a social security scheme
Key Trial Info
Start Date :
July 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 17 2024
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT04375579
Start Date
July 3 2020
End Date
October 17 2024
Last Update
June 26 2024
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France
2
CHU Angers
Angers, France
3
CHU Besancon
Besançon, France
4
CHU Bordeaux
Bordeaux, France